IDEXX Laboratories
$517.75Change from previous close: −0.85%Absolute change: −$4.44
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $40.84B
- Enterprise value
- $41.69B
- P/E (trailing 12 months)
- 36.4
- Forward P/E
- 30.9
- PEG
- 2.86
- Price/book
- 25.3
- Price/sales
- 8.97
- EV/EBITDA
- 25.7
- EV/revenue
- 9.16
Profitability and growth
- Gross margin
- 62.4%
- Operating margin
- 35.0%
- Net margin
- 25.0%
- ROE
- 74.2%
- ROA
- 27.1%
- Revenue growth (year over year)
- 9.7%
- Earnings growth (year over year)
- 17.6%
Financial health
- Total cash
- $196.93M
- Total debt
- $1.1B
- Debt/equity
- 0.68
- Current ratio
- 1.17
- Quick ratio
- 0.73
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $701.33
- Median price target
- $705.00
- High price target
- $805.00
- Low price target
- $470.00
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- $16.74
- EPS estimate, current year
- $14.83
Shares and trading
- Beta
- 1.54
- Average volume
- 570.9K
- Shares outstanding
- 78.88M
- Float
- 78.5M
- Institutional ownership
- 96.7%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 2.8%
- Short ratio (days)
- 3.82